![Karen Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Smith
Directeur/Bestuurslid bij
SKYE BIOSCIENCE, INC.
Vermogen: 220 557 $ op 30-06-2026
Profiel
Dr. Karen L. Smith is Chief Medical Officer bij Emergent BioSolutions, Inc., een Onafhankelijk Bestuurder bij Antares Pharma, Inc., een Onafhankelijk Bestuurder bij Sangamo Therapeutics, Inc. en een Onafhankelijk Bestuurder bij Acceleron Pharma, Inc. Ze zetelt in de Raad van Bestuur van Antares Pharma, Inc., Sangamo Therapeutics, Inc. en Acceleron Pharma, Inc. Dr. Smith was voorheen werkzaam als President & Chief Executive Officer bij Medeor Therapeutics, Inc., als Chief Executive Officer bij Eliminate Cancer, Inc., als Director & Vice President bij Celator Pharmaceuticals, Inc, een niet-uitvoerend bestuurder bij Forward Pharma A/S, een Chief Medical Officer & EVP-Research & Development bij Jazz Pharmaceuticals Plc, een SVP-Global Medical Affairs & Head-Dermatology bij Allergan, Inc., een Head-External Medical Relations bij AstraZeneca LP, een Head-US Clinical Operations bij Bristol Myers Squibb Co., en een Chief Executive Officer bij Boron Molecular Ltd. Zij was ook lid van de raad van bestuur van Sucampo Pharmaceuticals, Inc. Zij behaalde haar doctoraatsdiploma aan de Curtin University of Technology, een graduaatsdiploma aan de University of Salford, een MBA aan de University of New England (Australië), een doctoraatsdiploma aan de University of Warwick en een doctoraatsdiploma aan The University of Western Australia.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-04-2025 | 12.672 ( 0,01% ) | 215 044 $ | 30-06-2026 | |
| 12-06-2025 | 102.100 ( 0,02% ) | 5 513 $ | 30-06-2026 | |
| 31-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 | |
| 24-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Karen Smith
| Bedrijven | Functie | Begin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur/Bestuurslid | 28-06-2018 |
| EMYRIA LIMITED | Directeur/Bestuurslid | 29-11-2021 |
| SKYE BIOSCIENCE, INC. | Directeur/Bestuurslid | 02-07-2024 |
| CONTEXT THERAPEUTICS INC. | Directeur/Bestuurslid | 04-09-2024 |
Eerdere bekende functies van Karen Smith
| Bedrijven | Functie | Einde |
|---|---|---|
| TOUE BIOPAR | Directeur/Bestuurslid | 01-10-2023 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Hoofd Techniek/Wetenschap/O&O | 01-09-2023 |
| QUINCE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2023 |
| ANTARES PHARMA, INC. | Directeur/Bestuurslid | 24-05-2022 |
| EMERGENT BIOSOLUTIONS INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2021 |
Opleiding van Karen Smith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
78
Eerstegraads connecties
31
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 31 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Salford
 University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boron Molecular Ltd.
 Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Produces and distributes chemicals and compounds to the pharmaceutical and biotechnology industries | Process Industries |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New England (Australia)
 University of New England (Australia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Humanetics Corp.
 Humanetics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology, inflammatory diseases & biodefense drugs | Health Technology |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Curtin University of Technology
 Curtin University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emyria Ltd.
 Emyria Ltd. Packaged SoftwareTechnology Services Develops patient-centric care model technology | Technology Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Eliminate Cancer, Inc. | |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
